Paper62719
Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera.
Hersey P and 4 others. Int J Cancer, 1976. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Papers, record 62719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62719
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Cytotoxicity Tests, Immunologic | Major topic |
| Melanoma | Major topic |
| Antibodies | |
| Antibody Specificity | |
| Cell Line | |
| Cross Reactions | |
| Epitopes | |
| Histocompatibility Antigens | |
| Humans | |
| Immune Sera | |
| Leukocytes | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7438562 | Characterization of an inhibitor of cell division released in tumour cell cultures. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7438562 | PubMed |
| 7389213 | Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7389213 | PubMed |
| 6556949 | Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6556949 | PubMed |
| 3460702 | Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3460702 | PubMed |
| 646923 | Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients. | Br J Cancer | 1978 | https://conductscience.org/library/papers/646923 | PubMed |
| 301413 | Human E-rosette forming lymphocytes exhibiting antibody-dependent cytotoxic activity. | Blut | 1977 | https://conductscience.org/library/papers/301413 | PubMed |
| 91379 | Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays. | Br J Cancer | 1979 | https://conductscience.org/library/papers/91379 | PubMed |
| 78457 | [Limits and possibilities of neoplasm immunotherapy]. | Naturwissenschaften | 1978 | https://conductscience.org/library/papers/78457 | PubMed |
| 73378 | Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays. | Br J Cancer | 1977 | https://conductscience.org/library/papers/73378 | PubMed |
| 19029 | Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients. | Br J Cancer | 1977 | https://conductscience.org/library/papers/19029 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62719
GET https://conductscience.org/api/papers/v1/62719/authors